Geode Capital Management
IMGO

Geode Capital Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Geode Capital Management’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-467,992
Closed -$16.8M – 4946
2022
Q4 		$16.8M Buy
467,992
+20,609
+5% +$515K ﹤0.01% 1889
2022
Q3 		$6.73M Buy
447,383
+140,887
+46% +$2.29M ﹤0.01% 2507
2022
Q2 		$4.1M Buy
306,496
+42,458
+16% +$674K ﹤0.01% 2807
2022
Q1 		$5.09M Buy
264,038
+99,425
+60% +$2.06M ﹤0.01% 2791
2021
Q4 		$3.9M Buy
164,613
+19,799
+14% +$459K ﹤0.01% 3029
2021
Q3 		$2.9M Buy
+144,814
New +$3.11M ﹤0.01% 3198

Geode Capital Management's IMGO Position: Q1 2023 in Review

Geode Capital Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 467,992 shares — an estimated $16.8M sold.

Geode Capital Management first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $16.8M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Geode Capital Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • Geode Capital Management sold 467,992 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $16.8M.
  • Geode Capital Management first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
  • Geode Capital Management's Imago BioSciences, Inc. Common stock position peaked at $16.8M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.